Thank you very much, Madam Chair.
Thank you, Ms. Nguyen. I also want to thank the witnesses, namely Ms. Huntjens and Ms. Brunot, as well as Dr. Prévost, for being with us today. I appreciate it.
Right from the start, at the first meeting on this study, I said that it was much broader than just the issue of menopause from a health perspective. As has been noted, there are issues that characterize women's health, ranging from menstruation through pregnancy to premenopause, menopause and perimenopause. We can see that at every stage of life, women face certain realities. When the Standing Committee on Health examined the multi-faceted issue that is women's health, it sought to demystify the subject by asking whether there was a lack of research, a lack of evidence or a lack of knowledge.
Why do we always get the impression that when it comes to women's health, it's harder to find solutions and study the issue scientifically? That's what we hear. We're not talking about the economic aspect. There are prejudices against, for example, a teenage girl who misses school and is stigmatized; a woman in her twenties trying to get her first job who is asked outright if she plans to have children; a woman in her thirties or forties who is overwhelmed by her family life; or a woman whom employers assume, during the hiring process, will also experience the effects of perimenopause or menopause in her 40s or 50s.
And yet, as you pointed out, that's often when she's at the peak of her professional career. That's when women have typically acquired all their knowledge and could also succeed in earning a higher salary to prepare for retirement.
So this study is much broader in scope, both in terms of health and finances. Again, we need to demystify what falls under the purview of health administration. Doctors' offices are largely under Quebec's jurisdiction, while research and medications fall under federal jurisdiction. So we need to untangle all of that.
Let's start with the issue of health. We heard earlier that there are studies on perimenopause and menopause, but that the problem lies in the subsequent integration of that knowledge into medical practice.
Can you confirm this information that was shared with us by the previous witnesses?
Ms. Brunot, please go ahead and respond first.